JASON VANHOOSE: Open Payments
NPI 1932875788 · VINITA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,664 in 141 payments from 24 companies in 2025. Trend: 2023 $950 · 2024 $1,913 · 2025 $2,664
Food & beverage: $2,664
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $348 |
| Vanda Pharmaceuticals Inc. | 14 | $348 |
| Alkermes, Inc. | 16 | $340 |
| Lundbeck LLC | 15 | $252 |
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| Novo Nordisk Inc | 12 | $193 |
| Janssen Pharmaceuticals, Inc | 11 | $185 |
| Teva Pharmaceuticals USA, Inc. | 8 | $182 |
| ABBVIE INC. | 13 | $151 |
| Merck Sharp & Dohme LLC | 5 | $103 |
Products named: CAPLYTA, FANAPT, ARISTADA, REXULTI, INVEGA SUSTENNA, BEVESPI AEROSPHERE, AUSTEDO XR, VERQUVO.
Industry payments across OK — which companies pay providers there.
